2001
DOI: 10.1038/35098123
|View full text |Cite
|
Sign up to set email alerts
|

Erratum: correction: CREB regulates hepatic gluconeogenesis through the coactivator PGC-1

Abstract: In the third sentence,``hyperglycaemia'' should have read``hypoglycaemia''. The corrected sentence is: "Here we show that mice carrying a targeted disruption of the cyclic AMP (cAMP) response element binding (CREB) protein gene, or overexpressing a dominant-negative CREB inhibitor, exhibit fasting hypoglycaemia and reduced expression of gluconeogenic enzymes." M

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
5
0

Year Published

2004
2004
2020
2020

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 1 publication
0
5
0
Order By: Relevance
“…For example HIF-1 alpha is known to induce the expression of several genes regulating glycolysis such as hexokinase-2, phosphofructokinase, GAPDH, enolase-1 and LDHA [13]. Approximately 25% of the genes regulated by CREB play a role in the control of metabolic processes [26] and it has been observed that inhibition of CREB induces fastinghyperglycemia and reduces expression of gluconeogenic genes such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase [43]. Interestingly, it has also been demonstrated that ATF-3 is strongly induced in renal epithelial cells as a result of medium exhaustion [36] suggesting that selective activation of ATF-3 in A459 cells is a consequence of hypoxia induced glucose deprivation.…”
Section: Discussionmentioning
confidence: 99%
“…For example HIF-1 alpha is known to induce the expression of several genes regulating glycolysis such as hexokinase-2, phosphofructokinase, GAPDH, enolase-1 and LDHA [13]. Approximately 25% of the genes regulated by CREB play a role in the control of metabolic processes [26] and it has been observed that inhibition of CREB induces fastinghyperglycemia and reduces expression of gluconeogenic genes such as phosphoenolpyruvate carboxykinase and glucose-6-phosphatase [43]. Interestingly, it has also been demonstrated that ATF-3 is strongly induced in renal epithelial cells as a result of medium exhaustion [36] suggesting that selective activation of ATF-3 in A459 cells is a consequence of hypoxia induced glucose deprivation.…”
Section: Discussionmentioning
confidence: 99%
“…It is capable of driving transcriptional control of mitochondrial biogenesis through direct interaction with, and coactivation of, PPARs (Madrazo and Kelly, 2008), estrogen-related receptors (ERRs; Schreiber et al, 2004; Eichner and Giguère, 2011), nuclear respiratory factors (NRF-1/NRF-2; Wu et al, 1999; Scarpulla, 2011) and the transcription factor yin-yang one (YY1; Basu et al, 1997; Seelan and Grossman, 1997; Cunningham et al, 2007; Xi et al, 2007), which are important nuclear transcription factors controlling mitochondrial metabolism (Scarpulla et al, 2012). PGC-1 α is also an inducible responder to cellular energetic and metabolic stress, such as cold exposure (Puigserver et al, 1998; Uldry et al, 2006; Fisher et al, 2012), nutrient deprivation (Herzig et al, 2001; Yoon et al, 2001; Handschin et al, 2005; Rhee et al, 2006) and exercise (Baar et al, 2002; Handschin and Spiegelman, 2008) and is dynamically regulated in response to a variety of signaling pathways involved in cellular growth, differentiation and energy metabolism. Additionally, a large amount of evidence suggests that PGC-1 α links mitochondrial biogenesis and the response to oxidative stress.…”
Section: Pgc-1α As a Molecular Target Of Pvi-specific Gxementioning
confidence: 99%
“…It has been reported that methylation of CpG in CRE blocked pCREB binding (Iguchi-Ariga and Schaffner, 1989; Sunahori et al, 2009). CREB is an important regulator for PGC-1 α gene transcription (Herzig et al, 2001; St-Pierre et al, 2006). Barrès et al (2009) provided evidence that PGC-1 α hypermethylation is concomitant with reduced mitochondrial content in type 2 diabetic patients, and links DNMT3B to the acute fatty-acid-induced non-CpG methylation of PGC-1 α promoter.…”
Section: Pgc-1α As a Molecular Target Of Pvi-specific Gxementioning
confidence: 99%
“…PGC-1α mRNA levels are elevated in the liver of rodents in models of type 2 diabetes; this is likely due to alterations of hepatic insulin resistance. 38,39 Acute knockdown of PGC-1α in the liver improves hepatic insulin sensitivity and glucose tolerance in db/db mice. 40 Thus modulating PGC-1α activity in the liver may have important implications for systemic glucose homeostasis.…”
Section: Bfementioning
confidence: 99%